Email updates

Keep up to date with the latest news and content from European Journal of Medical Research and BioMed Central.

Open Access Research

Comparison of guideline recommendations with daily practice in patients with renal cell carcinoma

B Schlenker1*, M Seitz1, MJ Bader1, R Ganzer2, D Tilki1, F Bayrle1, O Reich1, M Staehler1, A Bachmann3, CG Stief1 and C Gratzke1

Author Affiliations

1 Department of Urology, University Hospital Grosshadern, Ludwig-Maximilians- University Munich, Germany

2 Department of Urology, Krankenhaus St. Josef, University of Regensburg, Germany

3 Department of Urology, Basel University Hospital, Switzerland

For all author emails, please log on.

European Journal of Medical Research 2010, 15:253-257  doi:10.1186/2047-783X-15-6-253

Published: 28 June 2010


Objectives and Aims

To compare guideline recommendations with daily practice patterns in a German patient cohort with renal cell carcinoma.

Patients and methods

81 patients with T1 oder T2 renal cell carcinoma (RCC) were included in this prospective single-center study. All patients were operated in a single institution either by open radical nephrectomy (ORN) or nephron sparing surgery (NSS). Patients and doctors were evaluated using a written questionnaire with a follow-up of 12 months. Follow-up intervals, follow-up modalities (e. g. imaging modalities, laboratory controls of blood and urine) and the call on psycho-oncological support were evaluated.


The majority of patients (72%) were followed up by their urologists. Follow-up examinations included abdominal ultrasound, urine and blood diagnostics, conventional chest x-rays, computed tomography (CT) of abdomen, chest or head or abdominal Magnetic Resonance Imaging (MRI). There were no significant differences between patients operated by ORN or NSS. In total, 12.5% of patients were asking for psycho-oncological support.


In general, patients were followed up according to existing guideline recommendations. Only a small proportion of patients asked for psycho-oncological treatment.

renal cell carcinoma; oncological follow-up; open radical nephrectomy; nephron-sparing surgery